To detect breast cancer when it can be cured
MammoWave is a revolutionary safe solution for the detection of breast lesions. Using microwave radiofrequency signals to perform imaging, its innovative technology is non-ionizing (free from X-rays), meaning there is no radiation risk.
The first breast test towards a paradigm shift in breast cancer prevention
MammoWave uses safe low-power (1 mW) radiofrequency signal in the microwave band (1-9 GHz), rather than dangerous X-rays.
MammoWave provides breast images, highlighting eventual lesions with high sensitivity and specificity. Performances hold for dense breasts.
MammoWave does not require any breast compression. A breast scan is completed whilst the person is in a horizontal face down position.
Performances are augmented by dedicated Artificial Intelligence (AI) algorithms
MammoWave is a novel, safe and accurate imaging device, which allows Hospitals and Clinics to promote a more inclusive breast examinations, also in young women
MammoWave is a patented device, with patent granted in EU, US and China. MammoWave is a CE-marked medical device (class IIa).
MammoWave has been clinically validated in the context of a Feasibility Clinical Trials (completed in 2020) and a Multicenter International Trial (completed in 2021). Further Clinical Trials are ongoing
MammoWave can be used in all the asymptomatic population, without any restrictions such as age and frequency of use
Ubt (Umbria Bioengineering Technologies) develops and commercialises a portfolio of innovative medical imaging devices based on cutting-edge microwaves technology instead of dangereous ionizing radiation. Ubt devices meet existing needs for safer imaging techniques providing patented, novel, cost-effective, accurate alternatives to current devices.
UBT Srl is a Benefit Company based in Assisi (Italy) with a Subsidiary in London. Founded in 2015 as an academic Spin Off of the University of Perugia, it has been awarded numerous grants under Horizon 2020 (European Commission). UBT activated and sponsored Clinical Trials in prestigious Italian and European hospitals. UBT is ISO 13485 certified.
BrainWave is a new medical device using safe microwave imaging technology to provide stroke pre-hospital classification
Do not hesitate to contact us. We will be happy to inform you about our innovative medical devices
Santa Maria della Spina Str., 25
06081 Rivotorto di Assisi (PG) Italy
VAT: 03434740548
Tel: +39 3490564302
gianluigi@ubt-tech.com (Scientific)
g.raspa@ubt-tech.com (Hardware)
s.tiberi@ubt-tech.com (Business)
amministrazione@ubt-tech.com (Administration)
3rd Floor 207 Regent Street, London, W1B 3HH (Registered)
103 Borough Rd, London, SE1 0AA (Operational)
Company number 13096679
According to the Italian Ministry of Health guidelines of 28/03/2013, the information contained in this website is exclusively intended for professional operators.
